• 1

    Jemal A, Siegel R, Ward E et al. . Cancer statistics, 2008. CA Cancer J Clin 2008;58:7196.

  • 2

    Olah K, Gee H, Blunt S et al. . Retrospective analysis of 318 cases of uterine sarcoma. Eur J Cancer 1991;27:10951099.

  • 3

    Ueda SM, Kapp DS, Cheung MK et al. . Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. Am J Obstet Gynecol 2008;198:218.e16.

    • Search Google Scholar
    • Export Citation
  • 4

    Duk JM, Aalders JG, Fleuren GJ et al. . CA 125: a useful marker in endometrial carcinoma. Am J Obstet Gynecol 1986;155:10971102.

  • 5

    Duk JM, Aalders JG, Fleuren GJ et al. . Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix. Obstet Gynecol 1989;73:661668.

    • Search Google Scholar
    • Export Citation
  • 6

    Patsner B, Orr JW Jr, Mann WJ Jr. Use of serum CA 125 measurement in posttreatment surveillance of early-stage endometrial carcinoma. Am J Obstet Gynecol 1990;162:427429.

    • Search Google Scholar
    • Export Citation
  • 7

    Rose PG, Sommers RM, Reale FR et al. . Serial serum CA 125 measurements for evaluation of recurrence in patients with endometrial carcinoma. Obstet Gynecol 1994;84:1216.

    • Search Google Scholar
    • Export Citation
  • 8

    Price FV, Chambers SK, Carcangiu ML et al. . CA 125 may not reflect disease status in patients with uterine serous carcinoma. Cancer 1998;82:17201725.

    • Search Google Scholar
    • Export Citation
  • 9

    Gimpelson RJ, Rappold HO. A comparative study between panoramic hysterectomy with directed biopsies and dilatation and curettage: a review of 276 cases. Am J Obstet Gynecol 1998;158:489492.

    • Search Google Scholar
    • Export Citation
  • 10

    Boronow RC, Morrow CP, Creasman WT et al. . Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol 1984;63:825832.

    • Search Google Scholar
    • Export Citation
  • 11

    Cowles TA, Magrina JF, Masterson BJ et al. . Comparison of clinical and surgical-staging in patients with endometrial carcinoma. Obstet Gynecol 1985;66:413416.

    • Search Google Scholar
    • Export Citation
  • 12

    Creasman WT, Morrow CP, Bundy BN et al. . Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study. Cancer 1987;60:20352041.

    • Search Google Scholar
    • Export Citation
  • 13

    Benedet JL, Bender H, Jones H III et al. . FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 2000;70:209262.

    • Search Google Scholar
    • Export Citation
  • 14

    American College of Obstetricians and Gynecologists. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol 2005;106:413425.

    • Search Google Scholar
    • Export Citation
  • 15

    Mariani A, Dowdy SC, Cliby WA et al. . Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 2008;109:1118.

    • Search Google Scholar
    • Export Citation
  • 16

    Chan JK, Wu H, Cheung MK et al. . The outcomes of 27,063 women with unstaged endometrioid uterine cancer. Gynecol Oncol 2007;106:282288.

  • 17

    Chan JK, Kapp DS. Role of complete lymphadenectomy in endometrioid uterine cancer. Lancet Oncol 2007;8:831841.

  • 18

    ASTEC study group Kitchener H, Swart AM et al. . Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009;373:125136.

    • Search Google Scholar
    • Export Citation
  • 19

    Benedetti Panici P, Basile S, Maneschi F et al. . Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008;100:17071716.

    • Search Google Scholar
    • Export Citation
  • 20

    Creasman WT, Odicino F, Maisonneuve P et al. . Carcinoma of the corpus uteri. FIGO 6th annual report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006;95(Suppl 1):S105143.

    • Search Google Scholar
    • Export Citation
  • 21

    Fishman DA, Roberts KB, Chambers JT et al. . Radiation therapy as exclusive treatment for medically inoperable patients with stage I and II endometrioid carcinoma of the endometrium. Gynecol Oncol 1996;61:189196.

    • Search Google Scholar
    • Export Citation
  • 22

    Daniel AG, Peters WA III. Accuracy of office and operating room curettage in the grading of endometrial carcinoma. Gynecol Oncol 1988;71:612614.

    • Search Google Scholar
    • Export Citation
  • 23

    Goff BA, Rice LW. Assessment of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol Oncol 1990;38:4648.

  • 24

    Kilgore LC, Partridge EE, Alvarez RD et al. . Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 1995;56:2933.

    • Search Google Scholar
    • Export Citation
  • 25

    Havrilesky LJ, Cragun JM, Calingaert B et al. . Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. Gynecol Oncol 2005;99:689695.

    • Search Google Scholar
    • Export Citation
  • 26

    Creutzberg CL, van Putten WL, Koper PC et al. . Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000;355:14041411.

    • Search Google Scholar
    • Export Citation
  • 27

    Aalders J, Abeler V, Kolstad P et al. . Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma. Clinical and histopathologic study of 540 patients. Obstet Gynecol 1980;56:419427.

    • Search Google Scholar
    • Export Citation
  • 28

    Keys HM, Roberts JA, Brunetto VL et al. . A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004;92:744751.

    • Search Google Scholar
    • Export Citation
  • 29

    Creutzberg CL, van Putten WL, Warlam-Rodenhuis CC et al. . Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial. J Clin Oncol 2004;22:12341241.

    • Search Google Scholar
    • Export Citation
  • 30

    Scholten AN, van Putten WL, Beerman H et al. . Postoperative radiotherapy for stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review. Int J Radiat Oncol Biol Phys 2005;63:834838.

    • Search Google Scholar
    • Export Citation
  • 31

    Alektiar KM, Venkatraman E, Chi DS, Barakat RR. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. Int J Radiat Oncol Biol Phys 2005;62:111117.

    • Search Google Scholar
    • Export Citation
  • 32

    Nout RA, Putter H, Jürgenliemk-Schulz IM et al. . Vaginal brachytherapy versus external beam pelvic radiotherapy for high-intermediate risk endometrial cancer: results of the randomized PORTEC-2 trial [abstract]. J Clin Oncol 2008;26:Abstract LBA5503.

    • Search Google Scholar
    • Export Citation
  • 33

    ASTEC/EN.5 Study Group Blake P, Swart AM et al. . Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet 2009;373:137146.

    • Search Google Scholar
    • Export Citation
  • 34

    Lee CM, Szabo A, Shrieve DC et al. . Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma. JAMA 2006;295:389397.

    • Search Google Scholar
    • Export Citation
  • 35

    Johnson N, Cornes P. Survival and recurrent disease after postoperative radiotherapy for early endometrial cancer: systematic review and meta-analysis. BJOG 2007;114:13131320.

    • Search Google Scholar
    • Export Citation
  • 36

    Kong A, Johnson N, Cornes P et al. . Adjuvant radiotherapy for stage I endometrial cancer. Cochrane Database Syst Rev 2007;CD003916.

  • 37

    Koh WJ, Tran AB, Douglas JG et al. . Radiation therapy in endometrial cancer. Best Pract Res Clin Obstet Gynaecol 2001;15:417432.

  • 38

    Hogberg T, Rosenberg P, Kristensen G et al. . A randomized phase-III study on adjuvant treatment with radiation (RT) ± chemotherapy (CT) in early-stage high-risk endometrial cancer (NSGO-EC-9501/EORTC 55991) [abstract]. J Clin Oncol 2007;25:Abstract 5503.

    • Search Google Scholar
    • Export Citation
  • 39

    Morrow CP, Bundy BN, Kurman RJ et al. . Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991;40:5565.

    • Search Google Scholar
    • Export Citation
  • 40

    Kadar N, Homesley HD, Malfetano JH. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease. Gynecol Oncol 1992;46:145149.

    • Search Google Scholar
    • Export Citation
  • 41

    Owen Mumford. Best Practice Guidelines on the Use of Vaginal Dilators in Women Receiving Pelvic radiotherapy. Available at: http://www.owenmumford.com/en/download.asp?id=59. Accessed March 25, 2009.

    • Search Google Scholar
    • Export Citation
  • 42

    Walker JL, Piedmonte M, Spirtos N et al. . Surgical staging of uterine cancer: randomized phase III trial of laparoscopy vs laparotomy—a Gynecologic Oncology Group study (GOG): preliminary results [Abstract]. J Clin Oncol 2006;24(Suppl 18):Abstract 5010.

    • Search Google Scholar
    • Export Citation
  • 43

    Malur S, Possover M, Michels W, Schneider A. Laparoscopic-assisted vaginal versus abdominal surgery in patients with endometrial cancer—a prospective randomized trial. Gynecol Oncol 2001;80:239244.

    • Search Google Scholar
    • Export Citation
  • 44

    Obermair A, Manolitsas TP, Leung Y et al. . Total laparoscopic hysterectomy for endometrial cancer: patterns of recurrence and survival. Gynecol Oncol 2004;92:789793.

    • Search Google Scholar
    • Export Citation
  • 45

    Boggess JF, Gehrig PA, Cantrell L et al. . A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy. Am J Obstet Gynecol 2008;199:360.e19.

    • Search Google Scholar
    • Export Citation
  • 46

    Bandera CA, Magrina JF. Robotic surgery in gynecologic oncology. Curr Opin Obstet Gynecol 2009;21:2530.

  • 47

    Chadha M, Nanavati PJ, Liu P et al. . Patterns of failure in endometrial carcinoma stage IB, grade 3 and IC patients treated with postoperative vaginal vault brachytherapy. Gynecol Oncol 1999;75:103107.

    • Search Google Scholar
    • Export Citation
  • 48

    Kong A, Powell M, Blake P. The role of postoperative radiotherapy in carcinoma of the endometrium. Clin Oncol (R Coll Radiol) 2008;20:457462.

    • Search Google Scholar
    • Export Citation
  • 49

    Solhjem MC, Petersen IA, Haddock MG. Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer. Int J Radiat Oncol Biol Phys 2005;62:13791384.

    • Search Google Scholar
    • Export Citation
  • 50

    Chi DS, Barakat RR, Palayekar MJ et al. . The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer 2008;18:269273.

    • Search Google Scholar
    • Export Citation
  • 51

    Gretz HF III, Economos K, Husain A et al. . The practice of surgical staging and its impact on adjuvant treatment recommendations in patients with stage I endometrial carcinoma. Gynecol Oncol 1996;61:409415.

    • Search Google Scholar
    • Export Citation
  • 52

    Ben-Shachar I, Pavelka J, Cohn DE et al. . Surgical staging for patients presenting with grade 1 endometrial carcinoma. Obstet Gynecol 2005;105:487493.

    • Search Google Scholar
    • Export Citation
  • 53

    Greven KM, Lanciano RM, Corn B et al. . Pathologic stage III endometrial carcinoma-prognostic factors and patterns of recurrence. Cancer 1993;71:36973702.

    • Search Google Scholar
    • Export Citation
  • 54

    Susumu N, Sagae S, Udagawa Y et al. . Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecol Oncol 2008;108:226233.

    • Search Google Scholar
    • Export Citation
  • 55

    Hogberg T. Adjuvant chemotherapy in endometrial carcinoma: overview of randomised trials. Clin Oncol (R Coll Radiol) 2008;20:463469.

  • 56

    Fleming G. Adjuvant therapy for high-risk adenocarcinoma of the uterus. ASCO Educational Book 2008:230233.

  • 57

    Gibbons S, Martinez A, Schray M et al. . Adjuvant whole abdominopelvic irradiation for high-risk endometrial carcinoma. Int J Radiat Oncol Biol Phys 1991;21:10191025.

    • Search Google Scholar
    • Export Citation
  • 58

    Greer BE, Hamberger AD. Treatment of intraperitoneal metastatic adenocarcinoma of the endometrium by the whole-abdomen moving-strip technique and pelvic boost irradiation. Gynecol Oncol 1983;16:365373.

    • Search Google Scholar
    • Export Citation
  • 59

    Randall ME, Filiaci VL, Muss H et al. . Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 2006;24:3644.

    • Search Google Scholar
    • Export Citation
  • 60

    Homesley HD, Filiaci V, Gibbons SK et al. . Randomized phase III trial in advanced endometrial carcinoma of surgery and volume-directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: a Gynecologic Oncology Group study [abstract]. 39th Annual Meeting of the Society of Gynecologic Oncologists; Tampa, FL; March 9, 2008. Abstract #1. Gynecol Oncol 2008;108:S2.

    • Search Google Scholar
    • Export Citation
  • 61

    Smith DC, Prentice R, Thompson DJ et al. . Association of exogenous estrogen and endometrial cancer. N Engl J Med 1975;293:11641167.

  • 62

    Ziel HK, Finkle WD. Increased incidence of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 1975;293:11671170.

  • 63

    Creasman WT, Henderson D, Hinshaw W et al. . Estrogen replacement therapy in the patient treated for endometrial cancer. Obstet Gynecol 1986;67:326330.

    • Search Google Scholar
    • Export Citation
  • 64

    Lee RB, Burke TW, Parke RC. Estrogen replacement therapy following treatment for stage I endometrial carcinoma. Gynecol Oncol 1990;36:189191.

    • Search Google Scholar
    • Export Citation
  • 65

    Chapman JA, DiSaia PJ, Osann K et al. . Estrogen replacement in surgical stage I and II endometrial cancer survivors. Am J Obstet Gynecol 1996;175:11951200.

    • Search Google Scholar
    • Export Citation
  • 66

    Gotlieb WH, Beiner ME, Shalmon B et al. . Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer. Obstet Gynecol 2003;102:718725.

    • Search Google Scholar
    • Export Citation
  • 67

    Ramirez PT, Frumovitz M, Bodurka DC et al. . Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol 2004;95:133138.

    • Search Google Scholar
    • Export Citation
  • 68

    Podczaski E, Kaminski P, Gurski K et al. . Detection and patterns of treatment failure in 300 consecutive cases of “early” endometrial cancer after primary surgery. Gynecol Oncol 1992;47:323327.

    • Search Google Scholar
    • Export Citation
  • 69

    Shumsky AG, Stuart GC, Brasher PM et al. . An evaluation of routine follow-up of patients treated for endometrial carcinoma. Gynecol Oncol 1994;55:229233.

    • Search Google Scholar
    • Export Citation
  • 70

    Berchuck A, Anspach C, Evans AC et al. . Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma. Gynecol Oncol 1995;59:2022.

    • Search Google Scholar
    • Export Citation
  • 71

    Reddoch JM, Burke TW, Morris M et al. . Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme. Gynecol Oncol 1995;59:221225.

    • Search Google Scholar
    • Export Citation
  • 72

    Greer BE, Goff BA, Koh WJ. Endometrial carcinoma. In: Johnson FE, Virgo KS, eds. Cancer Patient Follow-up. St. Louis: Mosby; 1997:357377.

  • 73

    Barakat RR, Goldman NA, Patel DA et al. . Pelvic exenteration for recurrent endometrial cancer. Gynecol Oncol 1999;75:99102.

  • 74

    Dowdy SC, Mariani A, Cliby WA et al. . Radical pelvic resection and intraoperative radiation therapy for recurrent endometrial cancer: technique and analysis of outcomes. Gynecol Oncol 2006;101:280286.

    • Search Google Scholar
    • Export Citation
  • 75

    Tran PT, Su Z, Hara W et al. . Long-term survivors using intraoperative radiotherapy for recurrent gynecologic malignancies. Int J Radiat Oncol Biol Phys 2007;69:504511.

    • Search Google Scholar
    • Export Citation
  • 76

    Poulsen MG, Roberts SJ. The salvage of recurrent endometrial carcinoma in the vagina and pelvis. Int J Radiat Oncol Biol Phys 1988;15:809813.

    • Search Google Scholar
    • Export Citation
  • 77

    Kauppila A. Oestrogen and progestin receptors as prognostic indicators in endometrial cancer. A review of the literature. Acta Oncol 1989;28:561566.

    • Search Google Scholar
    • Export Citation
  • 78

    Thigpen JT, Brady MF, Alvarez RD et al. . Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group. J Clin Oncol 1999;17:17361744.

    • Search Google Scholar
    • Export Citation
  • 79

    Quinn MA, Campbell JJ. Tamoxifen therapy in advanced/recurrent endometrial carcinoma. Gynecol Oncol 1989;32:13.

  • 80

    Thigpen T, Brady MF, Homesley HD et al. . Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 2001;19:364367.

    • Search Google Scholar
    • Export Citation
  • 81

    Burke TW, Walker CL. Arzoxifene as therapy for endometrial cancer. Gynecol Oncol 2003;90(2 Pt 2):S4046.

  • 82

    Quinn MA. Hormonal treatment of endometrial cancer. Hematol Oncol Clin North Am 1999;13:163187.

  • 83

    Fleming GF, Brunetto VL, Cella D et al. . Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 2004;22:21592166.

    • Search Google Scholar
    • Export Citation
  • 84

    Muss HB. Chemotherapy of metastatic endometrial cancer. Semin Oncol 1994;21:107113.

  • 85

    Reddy SP, Kudelka AP, Gonzalez de Leon C et al. . Tumors of the uterine corpus. In: Pazdur R, ed. Medical Oncology: A Comprehensive Review. Huntington: PRR; 1996:407416.

    • Search Google Scholar
    • Export Citation
  • 86

    Sovak MA, Dupont J, Hensley ML et al. . Paclitaxel and carboplatin in the treatment of advanced or recurrent endometrial cancer: a large retrospective study. Int J Gynecol Cancer 2007;17:197203.

    • Search Google Scholar
    • Export Citation
  • 87

    Secord AA, Havrilesky LJ, Carney ME et al. . Weekly low-dose paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer. Int J Clin Oncol 2007;12:3136.

    • Search Google Scholar
    • Export Citation
  • 88

    Goff BA, Kato D, Schmidt RA et al. . Uterine papillary serous carcinoma: patterns of metastatic spread. Gynecol Oncol 1994,53:264268.

  • 89

    Hendrickson MR, Longacre TA, Kempson RL. Uterine papillary serous carcinoma revisited. Gynecol Oncol 1994;54:261263.

  • 90

    McCluggage WG. Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas. Int J Gynecol Cancer 2002;12:687690.

    • Search Google Scholar
    • Export Citation
  • 91

    Kelly MG, O’Malley DM, Hui P et al. . Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Gynecol Oncol 2005;98:353359.

    • Search Google Scholar
    • Export Citation
  • 92

    Thomas MB, Mariani A, Cliby WA et al. . Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma. Gynecol Oncol 2007;107:186189.

    • Search Google Scholar
    • Export Citation
  • 93

    Goldberg H, Miller RC, Abdah-Bortnyak R et al. . Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN). Gynecol Oncol 2008;108:298305.

    • Search Google Scholar
    • Export Citation
  • 94

    Hamilton CA, Cheung MK, Osann K et al. . The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma. Gynecol Oncol 2006;103:679683.

    • Search Google Scholar
    • Export Citation
  • 95

    Grice J, Ek M, Greer BE et al. . Uterine papillary serous carcinoma (UPSC): evaluation of long-term survival in 36 surgically staged patients. Gynecol Oncol 1998;69:6973.

    • Search Google Scholar
    • Export Citation
  • 96

    Havrilesky LJ, Secord AA, Bae-Jump V et al. . Outcomes in surgical stage I uterine papillary serous carcinoma. Gynecol Oncol 2007;105:677682.

  • 97

    Mehta N, Yamada SD, Rotmensch J, Mundt AJ. Outcome and pattern of failure in pathologic stage I-II papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 2003;57:10041009.

    • Search Google Scholar
    • Export Citation
  • 98

    Murphy KT, Rotmensch J, Yamada SD, Mundt AJ. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 2003;55:12721276.

    • Search Google Scholar
    • Export Citation
  • 99

    Sood BM, Jones J, Gupta S et al. . Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma. Int J Radiat Oncol Biol Phys 2003;57:208216.

    • Search Google Scholar
    • Export Citation
  • 100

    Wolfson AH, Brady MF, Rocereto T et al. . A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus. Gynecol Oncol 2007;107:177185.

    • Search Google Scholar
    • Export Citation
  • 101

    Homesley HD, Filiaci V, Markman M et al. . Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group study. J Clin Oncol 2007;25:526531.

    • Search Google Scholar
    • Export Citation
  • 102

    Sutton G, Kauderer J, Carson LF et al. . Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study. Gynecol Oncol 2005;96:630634.

    • Search Google Scholar
    • Export Citation
  • 103

    Reed NS, Mangioni C, Malmström H et al. . Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group study (protocol 55874). Eur J Cancer 2008;44:808818.

    • Search Google Scholar
    • Export Citation
  • 104

    Callister M, Ramondetta LM, Jhingran A et al. . Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome. Int J Radiat Oncol Biol Phys 2004;58:786796.

    • Search Google Scholar
    • Export Citation
  • 105

    Chi D, Mychalczak B, Saigo P et al. . The role of whole-pelvic irradiation in the treatment of early-stage uterine carcinosarcoma. Gynecol Oncol 1997;65:493498.

    • Search Google Scholar
    • Export Citation
  • 106

    Knocke T, Weitmann H, Kucera H et al. . Results of primary and adjuvant radiotherapy in the treatment of mixed Mullerian tumors of the corpus uteri. Gynecol Oncol 1999;73:389395.

    • Search Google Scholar
    • Export Citation
  • 107

    Larson B, Silfversward C, Nilsson B et al. . Mixed mullerian tumours of the uterus—prognostic factors: a clinical and histopathologic study of 147 cases. Radiother Oncol 1990;17:123132.

    • Search Google Scholar
    • Export Citation
  • 108

    Gerszten K, Faul C, Kounelis S et al. . The impact of adjuvant radiotherapy on carcinosarcoma of the uterus. Gynecol Oncol 1998;68:813.

  • 109

    Dusenbery KE, Potish RA, Argenta PA, Judson PL. On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus. Am J Clin Oncol 2005;28:295300.

    • Search Google Scholar
    • Export Citation
  • 110

    Nemani D, Mitra N, Guo M, Lin L. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis. Gynecol Oncol 2008;111:8288.

    • Search Google Scholar
    • Export Citation
  • 111

    Wolfson AH, Brady MF, Rocereto T et al. . A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus. Gynecol Oncol 2007;107:177185.

    • Search Google Scholar
    • Export Citation
  • 112

    Pink D, Lindner T, Mrozek A et al. . Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature. Gynecol Oncol 2006;101:464469.

    • Search Google Scholar
    • Export Citation
  • 113

    Mansi J, Ramachandra S, Wiltshaw E et al. . Endometrial stromal sarcomas. Gynecol Oncol 1990;36:113118.

  • 114

    Berchuck A, Rubin S, Hoskins W et al. . Treatment of endometrial stromal tumors. Gynecol Oncol 1990;36:6065.

  • 115

    Weitmann H, Knocke T, Kucera H et al. . Radiation therapy in the treatment of endometrial stromal sarcoma. Int J Radiat Oncol Biol Phys 2001;49:739748.

    • Search Google Scholar
    • Export Citation
  • 116

    Brenner DJ, Hall EJ. Computed tomography—an increasing source of radiation exposure. N Engl J Med 2007;357:22772284.

  • 117

    Zivanovic O, Iasonos A, Leitao MM et al. . Stage-specific survival of patients with uterine leiomyosarcoma: a comparison of FIGO and AJCC staging system [abstract]. J Clin Oncol 2008;26:Abstract 5554.

    • Search Google Scholar
    • Export Citation
  • 118

    Giuntoli RN, Metzinger D, DiMarco C et al. . Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol 2003;89:460469.

    • Search Google Scholar
    • Export Citation
  • 119

    Dusenbery KE, Potish RA, Judson P. Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterus. Gynecol Oncol 2004;94:191196.

    • Search Google Scholar
    • Export Citation
  • 120

    Sarcoma Meta-analysis Collaboration (SMAC). Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults. Cochrane Database Syst Rev 2000;CD001419.

    • Search Google Scholar
    • Export Citation
  • 121

    Hensley ML, Maki R, Venkatraman E et al. . Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol 2002;20:28242831.

    • Search Google Scholar
    • Export Citation
  • 122

    Hensley ML, Blessing JA, Mannel R, Rose PG. Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial. Gynecol Oncol 2008;109:329334.

    • Search Google Scholar
    • Export Citation
  • 123

    Look KY, Sandler A, Blessing JA et al. . Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) study. Gynecol Oncol 2004;92:644647.

    • Search Google Scholar
    • Export Citation
  • 124

    Judson I, Radford JA, Harris M et al. . Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer 2001;37:870877.

    • Search Google Scholar
    • Export Citation
  • 125

    Sutton G, Blessing J, Hanjani P et al. . Phase II evaluation of liposomal doxorubicin (Doxil) in recurrent or advanced leiomyosarcoma of the uterus: a Gynecologic Oncology Group study. Gynecol Oncol 2005;96:749752.

    • Search Google Scholar
    • Export Citation
  • 126

    Gallup DG, Blessing JA, Andersen W et al. . Evaluation of paclitaxel in previously treated leiomyosarcoma of the uterus: a gynecologic oncology group study. Gynecol Oncol 2003;89:4851.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1900 775 69
PDF Downloads 1111 552 42
EPUB Downloads 0 0 0